Like many other tumor suppressor genes, PTEN is frequently dysregulated in cancers by genetic mutations (loss of function) and other molecular mechanisms, including downregulation of gene transcription and posttranslational modifications, leading to downregulation or even loss of protein expression and function. This evidence concerns the gene PTEN and cancer.